Azadine 150mg Injection

About Azadine 150mg Injection

Azadine 150mg Injection contains Azacitidine, is a chemotherapy agent commonly used for treating certain blood disorders, particularly myelodysplastic syndromes (MDS) and some cases of acute myeloid leukemia (AML). As an inhibitor of DNA methyltransferase, azacitidine targets aberrant cells to halt their growth and encourage cell death.

Notify your doctor of any liver or kidney problems, any other medications you take (particularly for infections), and if you are pregnant or nursing, do not use this medication.

Brand Name: Azadine

Composition: Azacitidine

Mechanism of Action:

Azacitidine inhibits DNA methyltransferase enzymes by acting as a hypomethylating agent. This results in DNA hypomethylation, which can normalize cell proliferation or cell death by reactivating tumor suppressor genes that are typically repressed in cancer cells. Additionally, it combines with RNA to prevent the creation of proteins in cells that divide quickly.

Uses:

• Myelodysplastic Syndromes
• Acute Myeloid Leukemia

Dosage and Administration:

The administration method is either intravenous infusion or subcutaneous injection. typically given seven days in a row every 28 days, or in accordance with a personalized regimen based on the needs and reaction of the patient.

Side Effects:

• Fatigue
• Weakness
• Nausea
• Vomiting
• Loss of appetite
• Diarrhea
• Constipation
• Anemia
• Neutropenia
• Thrombocytopenia
• Injection site reactions (redness, pain, or swelling)
•